NOVN:SWX
Novartis AG
CHF 116.46
arrow_upward
+0.28%(+0.32) 1D
Sep 22, 5:30:09 PM GMT+2 · CHF
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NOVN...
Open
CHF 115.58
High
CHF 116.68
Low
CHF 114.86
Mkt. cap
236.72B
Avg. vol.
3.01M
Volume
2.90M
Dividend
3.18%
Quarterly dividend
CHF 0.93
Ex-dividend date
Mar 10, 2026
P/E ratio
21.40
52-wk high
CHF 132.68
52-wk low
CHF 96.80
EPS
CHF 5.44
Shares outstanding
2.03B
No. of employees
75K
Open
CHF 115.58
High
CHF 116.68
Low
CHF 114.86
Mkt. cap
236.72B
Avg. vol.
3.01M
Volume
2.90M
Dividend
3.18%
Quarterly dividend
CHF 0.93
Ex-dividend date
Mar 10, 2026
P/E ratio
21.40
52-wk high
CHF 132.68
52-wk low
CHF 96.80
EPS
CHF 5.44
Shares outstanding
2.03B
No. of employees
75K
News stories
From web sources and news partners
www.marketscreener.com
·
10 hours ago
Europe Is Losing the Pharma Investment Race – But the Comeback Is Within Reach: An open letter from the Chairs of AstraZeneca, Boehringer Ingelheim, Chiesi Group, Ipsen, GSK, Novo, Novartis, Roche, and Sanofi
AD HOC NEWS
·
14 hours ago
Novartis stock gains as Cosentyx wins a new EU recommendation
AD HOC NEWS
·
19 hours ago
Novartis stock holds steady before the bell after September 21 close
Yahoo Finance
·
1 day ago
NVS Gets Positive CHMP Opinion for Cosentyx for Another Indication
Profile
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
About Novartis AG
CEOVasant Narasimhan
Employees75.3K
FoundedMar 7, 1996
HeadquartersBasel, Basel City, Switzerland
SectorPharmaceutical industry
Websitenovartis.com